Role of oncogenic transcription factor c-Myc in cell cycle regulation, apoptosis and metabolism

被引:31
作者
Dang, CV
Lewis, BC
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA
[5] Johns Hopkins Univ, Sch Med, Program Human Genet & Mol Biol, Baltimore, MD 21205 USA
基金
美国国家卫生研究院;
关键词
c-Myc; oncogene; transcription; cancer; metabolism; apoptosis;
D O I
10.1007/BF02258350
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The myc gene was initially discovered as a prototypical retrovirally transduced oncogene. Over the decades, abundant evidence has emerged to support a causal role for the activated cellular gene, c-myc, in animal and human tumors. The gene encodes an oncogenic helix-loop-helix leucine zipper transcription factor that acts as a heterodimer with its partner protein, Max, to activate genes regulating the cell cycle machinery as well as critical metabolic enzymes. The additional ability of c-Myc to repress transcription of differentiation-related genes suggest that c-Myc is a central and key molecular integrator of cell proliferation, differentiation and metabolism.
引用
收藏
页码:269 / 278
页数:10
相关论文
共 151 条
  • [11] Mxi1 tumor suppressor gene is not mutated in primary pancreatic adenocarcinoma
    Bartsch, D
    Peiffer, SL
    Kaleem, Z
    Wells, SA
    Goodfellow, PJ
    [J]. CANCER LETTERS, 1996, 102 (1-2) : 73 - 76
  • [12] THE HUMAN C-MYC-ONCOGENE - STRUCTURAL CONSEQUENCES OF TRANSLOCATION INTO THE IGH LOCUS IN BURKITT-LYMPHOMA
    BATTEY, J
    MOULDING, C
    TAUB, R
    MURPHY, W
    STEWART, T
    POTTER, H
    LENOIR, G
    LEDER, P
    [J]. CELL, 1983, 34 (03) : 779 - 787
  • [13] TFE3 - A HELIX LOOP HELIX PROTEIN THAT ACTIVATES TRANSCRIPTION THROUGH THE IMMUNOGLOBULIN ENHANCER MU-E3 MOTIF
    BECKMANN, H
    SU, LK
    KADESCH, T
    [J]. GENES & DEVELOPMENT, 1990, 4 (02) : 167 - 179
  • [14] THE ORNITHINE DECARBOXYLASE GENE IS A TRANSCRIPTIONAL TARGET OF C-MYC
    BELLOFERNANDEZ, C
    PACKHAM, G
    CLEVELAND, JL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (16) : 7804 - 7808
  • [15] AN EMBRYONICALLY EXPRESSED GENE IS A TARGET FOR C-MYC REGULATION VIA THE C-MYC-BINDING SEQUENCE
    BENVENISTY, N
    LEDER, A
    KUO, A
    LEDER, P
    [J]. GENES & DEVELOPMENT, 1992, 6 (12B) : 2513 - 2523
  • [16] CASEIN KINASE-II INHIBITS THE DNA-BINDING ACTIVITY OF MAX HOMODIMERS BUT NOT MYC MAX HETERODIMERS
    BERBERICH, SJ
    COLE, MD
    [J]. GENES & DEVELOPMENT, 1992, 6 (02) : 166 - 176
  • [17] BHATIA K, 1994, BLOOD, V84, P883
  • [18] POINT MUTATIONS IN THE C-MYC TRANSACTIVATION DOMAIN ARE COMMON IN BURKITTS-LYMPHOMA AND MOUSE PLASMACYTOMAS
    BHATIA, K
    HUPPI, K
    SPANGLER, G
    SIWARSKI, D
    IYER, R
    MAGRATH, I
    [J]. NATURE GENETICS, 1993, 5 (01) : 56 - 61
  • [19] RETROVIRUSES AND CANCER GENES
    BISHOP, JM
    [J]. ADVANCES IN CANCER RESEARCH, 1982, 37 : 1 - 32
  • [20] APOPTOTIC CELL-DEATH INDUCED BY C-MYC IS INHIBITED BY BCL-2
    BISSONNETTE, RP
    ECHEVERRI, F
    MAHBOUBI, A
    GREEN, DR
    [J]. NATURE, 1992, 359 (6395) : 552 - 554